EUROPEAN ASSOCIATION FOR CANCER RESEARCH
EACR202410-13 June 2024 Rotterdam
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| 17-EACR2024 | Variant-Specific Landscape of Mutual Exclusivity Among BRAF, EGFR, and KRAS Oncogenes in Human Cancer: Roadmap for Targeted Therapies | Maxim Noeparast |  Received |
 |
|||
| 66-EACR2024 | Survival and inferential analysis in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and subsequent sentinel lymph node ive biopsy. | Johanna Marcela Espejo Niño | Received |
|
|||
| 101-EACR2024 | How relevant are second line histological features? Five-year survival after pancreatoduodenectomy for confirmed pancreatic cancer | Caitlin Jordan | Received |
|
|||
| 102-EACR2024 | Enhancing Anti-Tumor Immunity through Talaporfin Sodium Photodynamic Therapy (TS-PDT) and Anti-Programmed Death 1 (Anti-PD-1) Antibody Combination Therapy | Hiromi Kataoka | Received |
|
|||
| 164-EACR2024 | Targeting alpha-synuclein to improve melanoma treatments | Panagiota S. Filippou | Received |
|
|||
| 217-EACR2024 | 3D Bioprinting of Personalised Brain Cancer Tumouroids | Philipp Graber | Received |
|
|||
| 240-EACR2024 | Preclinical development of FTX-001: First-in-class inhibitor of the long non-coding RNA MALAT1 | Marie-Aline Neveu | Received |
|
|||
| 254-EACR2024 | Oncoexporter: Conversion of NCI CRDC Data to the GA4GH Phenopacket Schema | Daoud Meerzaman | Received |
|
|||
| 306-EACR2024 | Identification of pre-sensitizing agents to FLT3 inhibitors in acute myeloid leukemia with lineage tracing | Johanna Eriksson | Received |
|
|||
| 309-EACR2024 | Tumor-infiltrating immune cells and HLA expression as potential biomarkers predicting response to PD-1 inhibitor therapy in stage IV melanoma patients | Andrea Ladányi | Received |
|
|||
| 322-EACR2024 | Introducing Sample Re-Interrogation for Progressive Development and On-line Analysis of High Parameter Spatial Biology Data | Sammi Garvey | Received |
|
|||
| 328-EACR2024 | A new method for cell-line and sample authentication using ultra low-pass whole genome sequencing | Alberto Ferrarini | Received |
|
|||
| 342-EACR2024 | Stereo-seq FFPE reveals the spatial profilings of long non-coding RNAs in lung cancer FFPE sample | Jie Yuan | Received |
|
|||
| 408-EACR2024 | circMETTL9 induces Apatinib resistance in gastric cancer via KRT16/NF-?B pathway | Zhou Hanyu | Received |
|
|||
| 410-EACR2024 | Ready to use Multiplex Immunofluorescence Panels Provide Reliable Deep Spatial Phenotyping for Diverse Immuno-Oncology Applications | Sammi Garvey | Received |
|
|||
| 420-EACR2024 | High-resolution Analysis of Immune Checkpoint Activation Utilizing a Combined in situ Proximity Ligation Assay (isPLA) and Multiplex Immunofluorescence (mIF) Imaging Approach | Sammi Garvey | Received |
|
|||
| 427-EACR2024 | DFF332, a novel potent and ive HIF2a transcription factor inhibitor for the treatment of VHL-deficient clear cell renal cell carcinoma | fritsch christine | Received |
|
|||
| 436-EACR2024 | Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes | Emma Hazelwood | Received |
|
|||
| 441-EACR2024 | Multi-Exposure High Dynamic Range Microscopy Eliminates the Need for Exposure Optimization in High-Plex Spatial Biology Applications | Sammi Garvey | Received |
|
|||
| 443-EACR2024 | Blunting Axitinib-related side effects with antioxidants | Maria Patrizia Mongiardi | Received |
|
|||
| 449-EACR2024 | Detection of low frequency variants from cell free DNA samples using a high sensitivity cfDNA library preparation with enrichment method | Edyta Bocian-Canepa | Received |
|
|||
| 450-EACR2024 | A Comprehensive Analytical Validation Framework for Immunofluorescence Assay Design Using CellScape Precise Spatial Multiplexing | Sammi Garvey | Received |
|
|||
| 577-EACR2024 | Eukaryotic translation initiation factor 4A3 inhibitors express differential effects on different subtypes of breast cancer | Jun Ling | Received |
|
|||
| 586-EACR2024 | Disrupting DOT1L epigenetic activity as a therapeutic strategy to trigger glioblastoma stem cell differentiation towards a neuronal-like state | Samir Assaf | Received |
|
|||
| 607-EACR2024 | Stroma-enriched ER Protein TXNDC5 Potentiates Pancreatic Adenocarcinoma Progression by Creating a Desmoplastic and Immunotolerant Microenvironment | Hsin Hui Wang | Received |
|
|||
| 616-EACR2024 | Exploring the metabolic profiling of Multiple Myeloma: implications for targeted therapies | Ludovica Di Martino | Received |
|
|||
| 626-EACR2024 | Meta-Analysis of 62 Cancer Expression Studies Including Potassium Channel (KCN) Genes Among Genes of Interest Reveals 4 KCN Groups in 85 of Studies and Highlights KCNMA1 and KCNN4 Genes | Beckner Marie | Received |
|
|||
| 628-EACR2024 | Tunable 3D cell models recapitulating the tumour microenvironment for in vitro immuno-oncology assays | Rachel Bleach | Received |
|
|||
| 668-EACR2024 | An RNAseq risk classifier to differentiate low- from high-risk Ducal Carcinoma In Situ of the breast | Lips Esther | Received |
|
|||
| 702-EACR2024 | Anti-leukemic Efficacy of Azacitidine relies on AML-intrinsic RNA Receptor Signaling, and secondary resistance can be overcome by pathway modulating all-trans-retinoic acid | Nadia El Khawanky | Received |
|
|||
| 800-EACR2024 | Development of a novel anti-TIGIT IL-15 fusion antibody for enhanced anti-tumour therapy | Rachel Etherington | Received |
|
|||
| 805-EACR2024 | Targeting Tumor Metabolism with Arginine Deprivation: A Novel Approach to Anticancer Therapy | Hung-Jung Wang | Received |
|
|||
| 830-EACR2024 | IFN-I and epigenetics behind tumor immunology | antonella sistigu | Received |
|
|||
| 837-EACR2024 | Monitoring cell health at scale in 3D matrix cultures is as easy as in 2D | Rachel Bleach | Received |
|
|||
| 946-EACR2024 | The proteasome activator complex, PA28ab, regulates stemness in glioblastoma. | Kyle Heemskerk | Received |
|
|||
| 951-EACR2024 | Characterization of a syngeneic cancer stem cell model of insulin-like growth factor 2 amplified glioblastoma. | H. Artee Luchman | Received |
|
|||
| 977-EACR2024 | Rasal1 impairment augments CD8 T cell antitumoral function in murine melanoma | Mark Issa | Received |
|
|||
| 1000-EACR2024 | LncRNA AFAP-1 is overexpressed in metastatic breast tumors and associated to vasculogenic mimicry. | Cesar Lopez-Camarillo | Received |
|
|||
| 1086-EACR2024 | Iron metabolism affects the survival of ovarian cancer cells in anchorage-independent culture conditions | Emanuele Giorgio | Received |
|
|||
| 1115-EACR2024 | Analytical performance of TruSight Oncology 500 ctDNA v2: Improved sensitivity for small nucleotide variants with reduced DNA input requirements and reduced hands-on time. | Nadia Sedlyarova | Received |
|
|||
| 1138-EACR2024 | Proteasomal inhibition enhances the efficacy of BCMA-targeting CART-cell therapy in multiple myeloma by preventing BCMA degradation | Leonie Rieger | Received |
|
|||
| 1188-EACR2024 | Evaluation of checkpoint inhibitor efficacy and/or engraftment in a humanized immune system mouse with and without transgenic human cytokine expression in a model lacking murine Fc gamma receptors. | Ivan Gladwyn-Ng | Received |
|
|||
| 1217-EACR2024 | Effect of combined treatments with Chlorogenic Acid and 5-Fluorouracil on Wnt/B-catenin pathway modulation in colorectal cancer. | Diego Fernando Uribe Yunda | Received |
|
|||
| 1231-EACR2024 | The role of snoRNAs in GBM cells, GSCs, neuronal precursor cells (NPCs), astrocytes, and normal brain tissues | Sujash Chatterjee | Received |
|
|||
| 1245-EACR2024 | High detection rate of somatic low frequency variants from FFPE samples using a versatile custom enrichment library preparation assay | Charlotte Crochet | Received |
|
|||
EACR2024
10-13 June 2024 Rotterdam
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
Poster submission deadline 30/09/2024
|
|
